Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study

NACompletedINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

September 1, 2019

Study Completion Date

October 1, 2019

Conditions
Bladder Cancer
Interventions
DIAGNOSTIC_TEST

Xpert bladder cancer monitor

Xpert Bladder Cancer Monitor, is a qualitative in vitro diagnostic test designed to monitor for the recurrence of bladder cancer in patients previously diagnosed with bladder cancer.The test utilizes a voided urine specimen and measures the levels of five targetmRNAs (ABL1, CRH, IGF2, UPK1B, ANXA10) by means of real-time, reverse transcription-polymerase chain reaction (RT-PCR). The Xpert Bladder Cancer Monitor is indicated as an aid to standard clinical evaluation in monitoring for bladder cancer recurrence in patients previously diagnosed with bladder cancer and should be used in conjunction with other clinical measures to assess disease recurrence.

Trial Locations (1)

35516

Urology and Nephrology Center, Al Mansurah

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cepheid

INDUSTRY

lead

Mansoura University

OTHER

NCT03715660 - Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study | Biotech Hunter | Biotech Hunter